Results of Using Re-washed Vials and Closures

Similar documents
LC-MS/MS Method for the Determination of Tenofovir from Plasma

SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

MS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine

GC-MS/MS Analysis of Benzodiazepines Using Analyte Protectants

Gas Chromatography Syringe Selection Guide

Achieving Secure Sealing and Instrument Handling in 9 mm Screw Thread Chromatography Vials

The Investigation of Factors Contributing to Immunosuppressant Drugs Response Variability in LC-MS/MS Analysis

Solving One of Chromatography s Biggest Dilemmas Proper Sealing of Chromatography Autosampler Vials

Comparison of Full Scan MS2 and MS3 Linear Ion Trap Approaches for Quantitation of Vitamin D

Fast and easy separation of 23 drugs of abuse. including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS

New Solvent Grade Targeted for Trace Analysis by UHPLC-MS

LC-MS/MS Method for the Determination of 21 Opiates and Opiate Derivatives in Urine

Impurity Profiling of Carbamazepine by HPLC/UV

Measuring Phytosterols in Health Supplements by LC/MS. Marcus Miller and William Schnute Thermo Fisher Scientific, San Jose, CA, USA

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

Rapid and sensitive UHPLC screening for water soluble vitamins in sports beverages

Rapid and sensitive UHPLC screening of additives in carbonated beverages with a robust organic acid column

Detection of oxygenated polycyclic aromatic hydrocarbons (oxy-pahs) in APCI mode with a single quadrupole mass spectrometer

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

LC-MS/MS Method for the Determination of Raloxifene and its Glucuronide Metabolites from Human Plasma Using SPE Micro Elution

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

Doubling the throughput of long chromatographic methods by using a novel Dual LC workflow

Quantitative Analysis of THC and Main Metabolites in Whole Blood Using Tandem Mass Spectrometry and Automated Online Sample Preparation

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

New Solvent Grade Targeted for Trace Analysis by UHPLC-MS

Rapid and Robust Detection of THC and Its Metabolites in Blood

Separation of 37 Fatty Acid Methyl Esters Utilizing a High-Efficiency 10 m Capillary GC Column with Optimization in Three Carrier Gases

New Solvent Grade Targeted for Trace Analysis by UHPLC-MS

LC/MS/MS Separation of Cholesterol and Related Sterols in Plasma on an Agilent InfinityLab Poroshell 120 EC C18 Column

Dayana Argoti, Kerry Hassell, Sarah J. Fair, and Joseph Herman Thermo Fisher Scientific, Franklin, MA, USA

Evaluation of an LC-MS/MS Research Method for the Analysis of 33 Benzodiazepines and their Metabolites

Mercury Speciation Determinations in Asian Dietary Supplements

Waters Sample Vials and Accessories

Testing robustness: Immunosuppressant drugs in blood with a TSQ Quantis MS for clinical research

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System

Analyze Drugs of Abuse with Agilent J&W Ultimate Plus Tubing in an Inert Flow Path

Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

Agilent 7700x ICP-MS

Enhanced LC-MS Sensitivity of Vitamin D Assay by Selection of Appropriate Mobile Phase

ab Lipid Peroxidation (MDA) Assay kit (Colorimetric/ Fluorometric)

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

Bioanalytical Quantitation of Biotherapeutics Using Intact Protein vs. Proteolytic Peptides by LC-HR/AM on a Q Exactive MS

LC-Based Lipidomics Analysis on QTRAP Instruments

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Determination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection. EPL-BAS Method No.

Providing a Universal, One-step Alternative to Liquid-Liquid Extraction in Bioanalysis

Increased Efficiency of Biomolecule Identification by Optimization of Trypsin Digestion Buffers

Detection of Low Level of Chloramphenicol in Milk and Honey with MIP SPE and LC-MS-MS

Ultimate Core Performance to Maximize Your Investment

Join the mass movement towards mass spectrometry

The Development of LC/MS Methods for Determination of MDMA (Ecstasy) and Metabolites in Biological Samples

Determination of Gamma-Hydroxy-Butyrate (GHB) in Biological Samples

Choose for Your Instrument. GC Supplies - Shimadzu Instrument Quick Pick Guide

Increased Identification Coverage and Throughput for Complex Lipidomes

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

Determination of Amantadine Residues in Chicken by LCMS-8040

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Shimadzu s Guide to Vial Selection. Not all vials are the same

Matrix Factor Determination with the Waters Regulated Bioanalysis System Solution

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Mass Spectrometry. Actual Instrumentation

Fatty Acid Mass Spectrometry Protocol Updated 10/11/2007 By Daren Stephens

MALAYSIAN MALAYSIAN COCOA WORKSHOP ON THE SAFE USE OF PESTICIDES IN COCOA AND HARMONIZED

The challenging extraction of non-polar contaminants out of a non-polar vegetable oil sample

Extraction of Multiple Mycotoxins From Grain Using ISOLUTE Myco prior to LC-MS/MS Analysis

Sample Concentration and Analysis of Human Hormones in Drinking Water

Automated Sample Preparation for Profiling Fatty Acids in Blood and Plasma using the Agilent 7693 ALS

Dienes Derivatization MaxSpec Kit

Lipidomic Analysis by UPLC-QTOF MS

ab65336 Triglyceride Quantification Assay Kit (Colorimetric/ Fluorometric)

Small Scale Preparative Isolation of Corticosteroid Degradation Products Using Mass-Based Fraction Collection Application

Detection and Quantification of Inorganic Arsenic in Fruit Juices by Capillary Ion Chromatography with Suppressed Conductivity Detection

CORESTA Recommended Method No. 84

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

Supporting information

Application Note. Author. Abstract. Introduction. Food Safety

Determination of Bath Salts (Pyrovalerone Analogs) in Biological Samples

Rapid and Direct Analysis of Free Phytosterols by Reversed Phase HPLC with Electrochemical Detection

Analysis of several common. organic acids in tobacco leaf, snus, and moist snuff

Lutein Esters from Tagetes Erecta

using the Agilent 7696A Sample Prep

ab Homocysteine Assay Kit (Fluorometric) 1

Analysis of Organic Acids and Alcohols Using the Agilent J&W DB-624UI Ultra Inert GC Column

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

ACE C18-AR Use the Power!

Determination of Chlorophenoxyacetic Acid and Other Acidic Herbicides Using a QuEChERS Sample Preparation Approach and LC-MS/MS Analysis

Method Development for the Analysis of Endogenous Steroids Using Convergence Chromatography with Mass Spectrometric Detection

Extraction of 11-nor-9-carboxy-tetrahydrocannabinol from Hydrolyzed Urine by ISOLUTE. SLE+ Prior to GC/MS Analysis

High Throughput Extraction of Opiates from Urine and Analysis by GC/MS or LC/MS/MS)

Ultra High Performance Liquid Chromatograph. Nexera X2 C196-E079

A High Sensitivity UPLC/MS/MS Method for the Analysis of Clopidogrel and Clopidogrel Carboxylic Acid Metabolite in Human K 2 EDTA Plasma

Efficient Quantitative Analysis of THC and Metabolites in Human Plasma Using Agilent Captiva EMR Lipid and LC-MS/MS

Uptake and Metabolism of Phthalate Esters by Edible Plants

Monitoring of plasmatic concentrations of AEDs is important to improve patient s theraphy.

Transcription:

Results of Using Re-washed Vials and Closures Loy Shick, Thermo Fisher Scientific, Rockwood, TN, USA Brian King, Thermo Fisher Scientific, Runcorn, Cheshire, UK Technical Note 20670 Key Words Autosampler, Closures, Contamination, Used Vials, Vial Cleaning, Vials Introduction When using glass autosampler vials in the laboratory, standard workflows require that vials and closures be considered consumable items and that they are discarded after each use. The use of laboratory dishwashers for the cleaning of laboratory glassware has sometimes been applied to autosampler vials. The cleaned vials are then utilized in the laboratory in hopes of reducing consumable costs. This note shows that this cleaning is causing both physical damage to the glass vials and is also ineffective at removing contamination from the vial surface. This contamination is unpredictable and produces interference peaks in both LC and GC chromatography applications. Unpredictable contamination can be a major source of unexplained assay failures resulting in the need to repeat the entire analysis of complete sample runs. The experimental work involved investigation of the physical effects of the washing process followed by the issues of contamination from the previous usage of both the vials and associated septa. Physical Effects of Re-washing Evaporation Variation Sample 1: Re-washed 9 mm screw thread vials were provided in clear glass Sample 2: Re-washed 9 mm screw thread vials were provided in amber glass Sample 3: New clear glass 9 mm vials (C4000-1W) and new closures with PTFE/silicone septa (C5000-54B) were provided by Thermo Scientific National as baseline reference samples

2 Room Temperature Evaporation Vials filled with methanol were allowed to sit at room temperature for 1 hour Initial weight was taken on a four place analytical balance The vials were loaded into a sample rack and allowed to sit at room temperature for 7 days Final room temperature weight was taken and the difference calculated as sample loss in grams High Temperature Evaporation The vials were returned to the rack and incubated at 40 C for 24 hours The final high temperature weight was taken and subtracted from the final room temperature eight to yield the 40 C sample loss in grams The evaporation data is compared in Figures 1a 1c. Evaporation levels are higher for all vials which have gone through the re-wash process. Impact of using any Septa which has been Re-used Figure 1d shows that any septa from the re-used vials and caps showed increased evaporative loss. This showed that the integrity had been lost due to the physical splitting of the PTFE and silicone layer. Septa Re-use Used Septum Evaluation 10 new 8-425 vials were filled with 100% methanol and capped with a new 8-425 closure with PTFE/Silicone pre-slit septum 10 re-used septa were hand inserted into a new 8-425 cap and attached to new 8-425 vials filled with 100% methanol Figure 1a Rewashed Amber Glass Vial (Sample 2) Sample Loss (g) 0.160 0.100 0.050-11 12 13 14 15 16 17 18 19 20 Sample Number 1 week RT 24 hour 40 C Figure 1b New C4000-1W Vials (Sample 3) Sample Loss (g) 0.160 0.020 21 22 23 24 25 26 27 28 29 30 (0.080) Sample Number 1 week RT 24 hour 40 C Figure 1c Reused 8-425 Septa Pre-slit Sample Loss (g) 1.000 0.500-41 42 43 44 45 46 47 48 49 50 Sample Number 1 week RT 24 hour 40 C Figure 1d Surface Deterioration Figure 2a: Typical amber and clear re-washed vials Figure 2b: Typical re-wash screw thread damage Figure 2c: Remains of identification patches on amber vials after re-washing Physically the vials exhibited damage to the threads and there was extensive abrasion on the vial surface. The extent of the abrasion was enough to have removed the write-on identification patches commonly found on this product. The removal was associated with the clouding of the glass limiting the transparency and visibility of sample levels (Figure 2a c).

3 Glass Surface Microstructure Chromatography vials are formed from high quality neutral borosilicate glass. Molten glass tubing is first drawn into long tubes of a specified outer diameter and wall thickness. The tubing is then reworked at high temperatures to form the closure profile and bottom shape of the vial. The vials are then annealed to remove stress and strengthen the glass before being packaged. The surface of the annealed glass is smooth and free of surface scratches and abrasions. When vials are re-washed they become scratched, abraded and plaques deposit on the surface. The surface is no longer free of stress, but through the scratching areas of potential, breakage and cracking can be identified (Figure 3). Post-annealing the neutral borosilicate glass may be considered to be a Type 1 glass with a homogenous surface chemically populated with siloxane bridges. Breaking of this surface both increase surface area and cleaves the siloxanes to release silanol groups on the glass surface. The increase in acidic silanols will increase the surface activity resulting in increased potential adsorption of any basic chemical species in the sample. The effect of physical damage to the vial surface and the thread can have far reaching consequences. The changes in evaporation rate from the vial will introduce uncertainty into the concentration of standards and samples Loss of solvent from the vials will change concentration and have impacts on recovery and precision of measurement even when using internal standards The change in surface characteristics will increase the risk of permanent sample adsorbtion within the vial, particularly of basic solutes The glass is weakened and breakage of the vials during autosampler transport cannot be discounted Clear Glass New Glass Surface Amber Glass New Glass Surface Clear Glass Re-washed Glass Surface Amber Glass Re-washed Glass Surface Figure 3: Comparison of new and re-washed glass vial surfaces

4 GC-MS Comparison of New Vials and Re-washed Products One milliliter samples of methanol used as a blank solvent were stored in a number of standard glass vials. Samples stored in new vials were then compared to samples injected from randomly selected re-washed vials. Two types of vials were used, amber and clear. The clear vials were all manufactured from 33 expansion neutral borosilicate glass. Amber vials were 51 expansion neutral borosilicate Type 1. All the re-washed vials had been subjected to multiple wash cycles. The new vial blank Total Ion Count (TIC) is compared to two amber vial blanks. The profiles from the two vials, show that Vial A has cyclic polysiloxanes as a contaminant while Vial B has additional impurity peaks. The contamination is not predictable, but is dependent on the samples previously in the vials (Figure 4). A similar blank comparison carried out with the clear 33 expansion vials also show great variation in both the intensity and profile of contaminants extracted from the vials. In this case, one vial showed that tailing species were extracted and distorted the GC baseline in a key part of the GC profile. Another vial tested in the same sequence showed much lower responses for all peaks (Figure 5). The use of such re-washed vials with GC-MS in TIC mode will lead to the production of significant impurity peaks that will interfere with analytical peaks or lead to poor quantification due to co-elution. GC-MS Method GC Instrument Thermo Scientific TRACE GC Oven 40 C (0.5 minute), 15 C/minute, 150 C (1 minute), 10 C/minute, 290 C (5 minute) SSL Left Carrier SSL Temp 250 C Columns MS Instrument Transferline Temp 290 C Ion Source Temp 230 C Ionization Source Electron Energy Scan Range Solvent Delay Autosampler Splitless (1 minute), 50 ml/minute split flow, constant septum purge Helium at 1.2 ml/minute, constant flow, Vacuum compensation ON Thermo Scientific TraceGOLD TG-5MS 30 m 0.25 mm 0.25 µm Thermo Scientific ISQ single quadrupole GC-MS EI 70 ev Sample Volume 1 µl Table 1 50 650 full scan, dwell time 0.2 seconds 3.5 minutes Thermo Scientific TriPlus RSH autosampler Figure 4: 10 20 minutes TIC screen

5 Figure 5 Impact of Re-using Septa In addition to re-using vials the extraction and re-use of injection septa may also be encountered. Figure 6: (Top) GC-MS and TIC trace showing components from siloxane extraction peaks. (Bottom) Siloxanes in particular are more easily extracted from damaged slit septa.

6 Effects on Instrumentation After carrying out three separate runs with the re-washed vials and septa, the performance of the GC started to deteriorate even with the clean blanks. The injection liner was inspected and deposits were found trapped in the liner. Some could be seen as black fragments which came from the discolored silicone layer. Deterioration of the septa can increase instrument down-time required for injection liner replacement and also cause carryover into standards and blanks. HPLC-UV Interferences Found in Gradient Profiling HPLC Instrument Thermo Scientific Accela 1250 PDA Mobile Phase A: Water/Formic acid 1% B: Acetonitrile A:B 5 95% 10 minutes Flow Rate Injection Volume 5 µl Detection Table 2 0.5 ml/minute PDA 210 nm, 220 nm, 254 nm A series of linear gradients were run and monitored by UV. Injections from the re-washed vials showed that a number of peaks were detected at 220 nm and 254 nm that were not present in the new vials samples. 6.0 Figure 7: Extract from gradient profile from re-washed vial

7 HPLC Instrument Column Thermo Scientific Accela 600 LCQ Deca XP Thermo Scientific Hypersil GOLD 3 µm 100 mm 2.1 mm Mobile Phase A: Water/Formic acid 1% B: Acetonitrile A:B 10 100%; B in 25 minutes Flow Rate Injection Volume 10 µl Detection 0.3 ml/minute +ESI MS Probe position C5 ESI needle voltage 4.5 kv Capillary temperature 300 C Capillary voltage 46 V Sheath gas 40 Auxiliary gas 10 Full scan 50 to 1500 Microscans 3 HPLC-MS Comparison of Background Signal from Re-used Septa against New Septa and Vial Combinations The presence of siloxane contamination from re-used septa may be shown by the additional mass peaks shown in the scan from a gradient elution similar to the UV scans below. Sample incubated with methanol at 30 C for 12 hours with 1) Clear new vial and Silicone/PTFE septa 2) Clear re-washed vial with a recycled split septa. Background MS signal increased by factor of 5 compared to new vial and septa combination when samples are compared using the instrument conditions shown in Table 3. Table 3: HPLC-MS m/z Figure 8: Comparison of blank with contaminated vial using the Silicone/PTFE septa

Summary The use of re-washed vials and re-using septa is compared to the use of new vials. Comparison of blank injections from such re-washed vials was carried out with GC and HPLC instrumentation In all cases additional components were found in the GC-MS blanks. Interference with standards was found in the TIC mode. GC-Instrumentation down time was increased due to an increased rate of injection liner replacement In HPLC, the introduction of even small volume injections showed introduction of additional peaks in the UV mode Comparison of contaminated and new vials was clearly shown by a full mass range scan When re-used septa were added the contamination of the injection from the vials was increased Conclusion Optimal chromatography results can be compromised by the use of re-used/re-washed vials and septa. Re-used/re-washed vials and septa can introduce random non-reproducible interference peaks into otherwise stable chromatographic methods. This can be a major source of unexplained assay failures that often require retesting entire sample runs, sometimes from the initial prep stages. Time spent in retests and troubleshooting an assay failure that cannot be duplicated negates any perceived benefits of re-using vials and septa. Chromatographers requiring uncompromising sample integrity would be best advised to always use new vials and septa for each analysis. Technical Note 20670 For more information, visit our website at www.thermoscientific.com/vials 2013 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific Inc. and its subsidiaries. This information is presented as an example of the capabilities of Thermo Fisher Scientific Inc. products. It is not intended to encourage use of these products in any manners that might infringe the intellectual property rights of others. Specifications, terms and pricing are subject to change. Not all products are available in all countries. Please consult your local sales representative for details. USA and Canada +1 800 332 3331 Australia 1300 735 292 (free call domestic) China +86 21 68654588 +86 10 84193588 +86 20 83145199 800 810 5118 France +33 (0)1 60 92 48 34 Germany +49 (0) 2423 9431 20 or 21 India +91 22 6742 9494 +91 27 1766 2352 Japan +81 3 5826 1615 United Kingdom +44 (0) 1928 534 110 New Zealand 0800 933 966 (free call domestic) All Other Enquiries +44 (0) 1928 534 050 Technical Support North America +1 800 332 3331 Outside North America +44 (0) 1928 534 440 TN20670_E 02/13M